Warning: The NCBI web site requires JavaScript to function. more...
GSK3 and p53 - is there a link in Alzheimer's disease?
Proctor CJ, Gray DA.
Mol Neurodegener. 2010 Jan 26;5:7.
Related citations
The molecular bases of Alzheimer's disease and other neurodegenerative disorders.
Maccioni RB, Muñoz JP, Barbeito L.
Arch Med Res. 2001 Sep-Oct;32(5):367-81. Review.
Glycogen synthase kinase3 beta phosphorylates serine 33 of p53 and activates p53's transcriptional activity.
Turenne GA, Price BD.
BMC Cell Biol. 2001;2:12. Epub 2001 Jul 16.
Activation of p53-dependent apoptosis by acute ablation of glycogen synthase kinase-3beta in colorectal cancer cells.
Ghosh JC, Altieri DC.
Clin Cancer Res. 2005 Jun 15;11(12):4580-8.
Direct, activating interaction between glycogen synthase kinase-3beta and p53 after DNA damage.
Watcharasit P, Bijur GN, Zmijewski JW, Song L, Zmijewska A, Chen X, Johnson GV, Jope RS.
Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):7951-5. Epub 2002 Jun 4.
Interplay between cyclin-dependent kinase 5 and glycogen synthase kinase 3 beta mediated by neuregulin signaling leads to differential effects on tau phosphorylation and amyloid precursor protein processing.
Wen Y, Planel E, Herman M, Figueroa HY, Wang L, Liu L, Lau LF, Yu WH, Duff KE.
J Neurosci. 2008 Mar 5;28(10):2624-32.
Glycogen synthase kinase-3beta (GSK3beta) binds to and promotes the actions of p53.
Watcharasit P, Bijur GN, Song L, Zhu J, Chen X, Jope RS.
J Biol Chem. 2003 Dec 5;278(49):48872-9. Epub 2003 Sep 30.
Neuroprotective effects of regulators of the glycogen synthase kinase-3beta signaling pathway in a transgenic model of Alzheimer's disease are associated with reduced amyloid precursor protein phosphorylation.
Rockenstein E, Torrance M, Adame A, Mante M, Bar-on P, Rose JB, Crews L, Masliah E.
J Neurosci. 2007 Feb 21;27(8):1981-91.
The binding and phosphorylation of Thr231 is critical for Tau's hyperphosphorylation and functional regulation by glycogen synthase kinase 3beta.
Lin YT, Cheng JT, Liang LC, Ko CY, Lo YK, Lu PJ.
J Neurochem. 2007 Oct;103(2):802-13. Epub 2007 Aug 6.
Spectroscopic studies of GSK3{beta} phosphorylation of the neuronal tau protein and its interaction with the N-terminal domain of apolipoprotein E.
Leroy A, Landrieu I, Huvent I, Legrand D, Codeville B, Wieruszeski JM, Lippens G.
J Biol Chem. 2010 Oct 22;285(43):33435-44. Epub 2010 Aug 2.
Inhibition of glycogen synthase kinase-3beta downregulates total tau proteins in cultured neurons and its reversal by the blockade of protein phosphatase-2A.
Martin L, Magnaudeix A, Esclaire F, Yardin C, Terro F.
Brain Res. 2009 Feb 3;1252:66-75. Epub 2008 Nov 30.
Glycogen synthase kinase-3beta is complexed with tau protein in brain microtubules.
Sun W, Qureshi HY, Cafferty PW, Sobue K, Agarwal-Mawal A, Neufield KD, Paudel HK.
J Biol Chem. 2002 Apr 5;277(14):11933-40. Epub 2002 Jan 25.
Akt/GSK3beta serine/threonine kinases: evidence for a signalling pathway mediated by familial Alzheimer's disease mutations.
Ryder J, Su Y, Ni B.
Cell Signal. 2004 Feb;16(2):187-200.
The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling.
Grimes CA, Jope RS.
Prog Neurobiol. 2001 Nov;65(4):391-426. Review. Erratum in: Prog Neurobiol 2001 Dec;65(5):497.
Morin attenuates tau hyperphosphorylation by inhibiting GSK3β.
Gong EJ, Park HR, Kim ME, Piao S, Lee E, Jo DG, Chung HY, Ha NC, Mattson MP, Lee J.
Neurobiol Dis. 2011 Nov;44(2):223-30. doi: 10.1016/j.nbd.2011.07.005. Epub 2011 Jul 18.
Final Report on Carcinogens Background Document for Formaldehyde.
National Toxicology Program.
Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.
B vitamin deficiency promotes tau phosphorylation through regulation of GSK3beta and PP2A.
Nicolia V, Fuso A, Cavallaro RA, Di Luzio A, Scarpa S.
J Alzheimers Dis. 2010;19(3):895-907.
Tau phosphorylation and neuronal apoptosis induced by the blockade of PP2A preferentially involve GSK3β.
Martin L, Page G, Terro F.
Neurochem Int. 2011 Aug;59(2):235-50. Epub 2011 Jun 6.
Regulation of cell survival mechanisms in Alzheimer's disease by glycogen synthase kinase-3.
Mines MA, Beurel E, Jope RS.
Int J Alzheimers Dis. 2011;2011:861072. Epub 2011 May 11.
Glycogen synthase kinase 3beta (GSK3beta) mediates 6-hydroxydopamine-induced neuronal death.
Chen G, Bower KA, Ma C, Fang S, Thiele CJ, Luo J.
FASEB J. 2004 Jul;18(10):1162-4. Epub 2004 May 7.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on